• Hyperphosphatemia Treatment Innovations: Phosphate Absorption Inhibitor (PAI)

  • Mar 26 2024
  • Length: 21 mins
  • Podcast

Hyperphosphatemia Treatment Innovations: Phosphate Absorption Inhibitor (PAI)

Listen for free

View show details

  • Summary

  • In part two of this 2-episode mini-series, our panelists discuss the recent approval of tenapanor for hyperphosphatemia management in patients on dialysis by the United States Food & Drug Administration (FDA). Tune into this discussion where our expert panelists share how the phosphate absorption inhibitor (PAI) works, factors to consider when integrating this agent into a patient’s treatment regimen, and how it may impact hyperphosphatemia management moving forward.

    Learning objectives:

    1. Describe the primary pathways for phosphate absorption.
    2. Explain the potential role(s) for a phosphate absorption inhibitor (PAI) for people with CKD who are on dialysis.

    Host: Sam Kant, MD Guests: Alexander Leidner, MD; Annabel Biruete, RD, PhD; Alex Berrios

    Supported by a grant from Ardelyx.

    Don't miss Part 1 in this series! Listen to: Patient & Clinician Experiences with Hyperphosphatemia: The Current Landscape
    Show more Show less
Physical Illness & Disease Hygiene & Healthy Living Science
Show more Show less

What listeners say about Hyperphosphatemia Treatment Innovations: Phosphate Absorption Inhibitor (PAI)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available